NFKB1 and cancer: Dysregulation of NF‐κB is a hallmark of cancer and can promote genetic and epigenetic alterations, change cellular metabolism, directly and indirectly control inflammation, cancer cell proliferation and survival, epithelial‐to‐mesenchymal transition, invasion, angiogenesis, and metastasis [49].